feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
IDL Biotech: Q2 review
Research Note
2019-08-22
09:09
IDL reports sales in line, but a lower negative EBIT than expected. We provide you with a short review of the report.
LS
Ludvig Svensson
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans